MFAP4 as a novel biomarker for predicting liver fibrosis and prognosis in infants with biliary atresia through the integration of bioinformatics with clinical data analysis.

High serum MFAP4 levels were significantly associated with reduced native liver survival rates, and emerged as a highly significant risk factor for liver transplantation or death during follow-up HR: 3.82 (95% CI, 1.35–10.06), p = 0.011 ( P < 0.05, Figure 4D ).

also in 132,142 other papers